BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 35393978)

  • 1. Patient outcomes and tumor control in single-fraction versus hypofractionated stereotactic body radiation therapy for spinal metastases.
    Park C; Howell EP; Mehta VA; Ramirez L; Price MJ; Floyd SR; Kirkpatrick JP; Torok J; Abd-El-Barr MM; Karikari IO; Goodwin CR
    J Neurosurg Spine; 2020 Nov; 34(2):293-302. PubMed ID: 33157523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy for spinal metastases: A new standard of care.
    Sacino AN; Chen H; Sahgal A; Bettegowda C; Rhines LD; Maralani P; Redmond KJ
    Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S76-S87. PubMed ID: 38437670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
    Hasan S; Abel S; Verma V; Webster P; Arscott WT; Wegner RE; Kirichenko A; Simone CB
    J Gastrointest Oncol; 2019 Oct; 10(5):999-1009. PubMed ID: 31602338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
    Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
    Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases: Real-world Outcomes From an International Multi-institutional SBRT Registry.
    Singh R; Valluri A; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2022 May; 45(5):196-201. PubMed ID: 35393978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for spinal metastases: a review.
    Guo L; Ke L; Zeng Z; Yuan C; Wu Z; Chen L; Lu L
    Med Oncol; 2022 May; 39(5):103. PubMed ID: 35599266
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.